-
QuickStats: Life Expectancy at Birth, by Sex - National Vital Statistics System, United States, 2019-2021. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-07-14
-
Updated Operational Guidance for Implementing CDC's Recommendations on Testing for Hepatitis C Virus Infection. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-07-14 Emily J Cartwright,Priti Patel,Saleem Kamili,Carolyn Wester
Current hepatitis C virus (HCV) testing guidance recommends a two-step testing sequence for diagnosis of HCV infection. Performing an HCV RNA test whenever an HCV antibody test is reactive (complete testing) is critical to achieve national HCV elimination goals. When an HCV antibody test is reactive and no HCV RNA test is performed, testing is considered incomplete. Historically, approximately one
-
Notes from the Field: Emergency Department Visits for Nonfatal Pedal Cyclist Injuries Before and During the COVID-19 Pandemic, United States, 2019-2020. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-07-14 Livia Navon,Keming Yuan,Laurie Beck
-
Notes from the Field: Multipathogen Respiratory Virus Testing Among Primary and Secondary School Students and Staff Members in a Large Metropolitan School District - Missouri, November 2, 2022-April 19, 2023. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-07-14 Jennifer L Goldman,Brian R Lee,Janelle Porter,Anila Deliu,Shannon Tilsworth,Olivia M Almendares,Sadia Sleweon,Hannah L Kirking,Rangaraj Selvarangan,Jennifer E Schuster
-
Cannabis-Involved Emergency Department Visits Among Persons Aged <25 Years Before and During the COVID-19 Pandemic - United States, 2019-2022. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-07-14 Douglas R Roehler,Herschel Smith,Lakshmi Radhakrishnan,Kristin M Holland,Abigail L Gates,Alana M Vivolo-Kantor,Brooke E Hoots
To understand trends in U.S. cannabis-involved emergency department (ED) visits (i.e., those for which cannabis use was documented in the chief complaint or a discharge diagnosis) among young persons aged <25 years during the COVID-19 pandemic, CDC used National Syndromic Surveillance Program data to examine changes in ED visits during 2019-2022. Mean weekly cannabis-involved ED visits among all young
-
Status of New Vaccine Introduction - Worldwide, 2016-2021. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-07-07 Gurpreet Kaur,Rebecca M Casey,Jaymin C Patel,Paul Bloem,Jenny A Walldorf,Terri B Hyde
This report describes the status of introductions globally for eight World Health Organization (WHO)-recommended new and underutilized vaccines, comprising 10 individual vaccine antigens. By 2021, among 194 countries worldwide, 33 (17%) provided all of these 10 WHO-recommended antigens as part of their routine immunization schedules; only one low-income country had introduced all of these recommended
-
Notes from the Field: Doubling of Cyclosporiasis Cases Partially Attributable to a Salad Kit - Florida, 2021-2022. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-07-07 Paul Rehme
-
Inpatient Hospitalization Costs Associated with Birth Defects Among Persons Aged <65 Years - United States, 2019. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-07-07 Justin Swanson,Elizabeth C Ailes,Janet D Cragan,Scott D Grosse,Jean Paul Tanner,Russell S Kirby,Norman J Waitzman,Jennita Reefhuis,Jason L Salemi
Changing treatments and medical costs necessitate updates to hospitalization cost estimates for birth defects. The 2019 National Inpatient Sample was used to estimate the service delivery costs of hospitalizations among patients aged <65 years for whom one or more birth defects were documented as discharge diagnoses. In 2019, the estimated cost of these birth defect-associated hospitalizations in the
-
Notes from the Field: Scrub Typhus Outbreak - Los Lagos Region, Chile, January-February 2023. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-07-07 Thomas Weitzel,Constanza Martínez-Valdebenito,Gerardo Acosta-Jamett,Katia Abarca
-
Notes from the Field: Multistate Outbreak of Escherichia coli O157:H7 Infections Linked to a National Fast-Food Chain - United States, 2022. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-30 Christan Stager,Danielle Donovan,Lauren Edwards,Evelyn Pereira,Laurie Williams,Jennifer Freiman,Colin Schwensohn,Laura Gieraltowski
-
Disparities in COVID-19 Disease Incidence by Income and Vaccination Coverage - 81 Communities, Los Angeles, California, July 2020-September 2021. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-30 John M Masterson,Michael Luu,Kai B Dallas,Lauren P Daskivich,Brennan Spiegel,Timothy J Daskivich
COVID-19 has disproportionately affected socially vulnerable communities characterized by lower income, lower education attainment, and higher proportions of minority populations, among other factors (1-4). Disparities in COVID-19 incidence and the impact of vaccination on incidence disparities by community income were assessed among 81 communities in Los Angeles, California. Median community vaccination
-
Illicitly Manufactured Fentanyl-Involved Overdose Deaths with Detected Xylazine - United States, January 2019-June 2022. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-30 Mbabazi Kariisa,Julie O'Donnell,Sagar Kumar,Christine L Mattson,Bruce A Goldberger
In 2022, provisional data indicated that more than two thirds (68%) of the reported 107,081 drug overdose deaths in the United States involved synthetic opioids other than methadone, principally illicitly manufactured fentanyls (IMFs) (1). Xylazine, a nonopioid sedative not approved for human use and with no known antidote, has been increasingly detected in IMF products in the U.S. drug supply* and
-
Expression of Concern: Timing of Introduction of Complementary Foods - United States, 2016-2018. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-30
-
Prevalence of Adverse Childhood Experiences Among U.S. Adults - Behavioral Risk Factor Surveillance System, 2011-2020. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-30 Elizabeth A Swedo,Maria V Aslam,Linda L Dahlberg,Phyllis Holditch Niolon,Angie S Guinn,Thomas R Simon,James A Mercy
Adverse childhood experiences (ACEs) are defined as preventable, potentially traumatic events that occur among persons aged <18 years and are associated with numerous negative outcomes; data from 25 states indicate that ACEs are common among U.S. adults (1). Disparities in ACEs are often attributable to social and economic environments in which some families live (2,3). Understanding the prevalence
-
Notes from the Field: Outbreak of Cryptosporidiosis Among Collegiate Swimmers and Evidence of Secondary Transmission - Massachusetts and Rhode Island, 2023. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-30 Geena Chiumento,Anthony Osinski,Kelsey DeVoe,Amelia Houghton,Akita Joshi,Caryn Ivanof,Emma Creegan,Michael Gosciminski,Alexandra P Newman,Susan Madison-Antenucci,Michele C Hlavsa,Erin Imada,Colleen Lysen,Shanna Miko,Jordan Schultz,Emily Harvey,Johanna Vostok,Catherine M Brown
-
Hepatitis C Virus Clearance Cascade - United States, 2013-2022. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-30 Carolyn Wester,Ademola Osinubi,Harvey W Kaufman,Hasan Symum,William A Meyer,Xiaohua Huang,William W Thompson
Approximately 2.4 million adults were estimated to have hepatitis C virus (HCV) infection in the United States during 2013-2016 (1). Untreated, hepatitis C can lead to advanced liver disease, liver cancer, and death (2). The Viral Hepatitis National Strategic Plan for the United States calls for ≥80% of persons with hepatitis C to achieve viral clearance by 2030 (3). Characterizing the steps that follow
-
Trends in Laboratory-Confirmed SARS-CoV-2 Reinfections and Associated Hospitalizations and Deaths Among Adults Aged ≥18 Years - 18 U.S. Jurisdictions, September 2021-December 2022. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-23 Kevin C Ma,Vajeera Dorabawila,Tomás M León,Hannah Henry,Amelia G Johnson,Eli Rosenberg,Joshua A Mansfield,Claire M Midgley,Ian D Plumb,Julia Aiken,Quratul Ain Khanani,Steven Auche,Nagla S Bayoumi,Sarah A Bennett,Carmen Bernu,Carolyn Chang,Kathryn J Como-Sabetti,Kevin Cueto,Spencer Cunningham,Meredith Eddy,Rebecca A Falender,Aaron Fleischauer,Darren M Frank,Pauline Harrington,Mikhail Hoskins,Adam Howsare
Although reinfections with SARS-CoV-2 have occurred in the United States with increasing frequency, U.S. epidemiologic trends in reinfections and associated severe outcomes have not been characterized. Weekly counts of SARS-CoV-2 reinfections, total infections, and associated hospitalizations and deaths reported by 18 U.S. jurisdictions during September 5, 2021-December 31, 2022, were analyzed overall
-
Notes from the Field: Emergence of an Mpox Cluster Primarily Affecting Persons Previously Vaccinated Against Mpox - Chicago, Illinois, March 18-June 12, 2023. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-23 Emily A G Faherty,Taylor Holly,Yasmin P Ogale,Gordon Crisler,Ashley Becht,David Kern,Lavinia Nicolae,Hillary Spencer,Michael Wasz,Janna L Kerins,Alyse Kittner,Amber Staton,Carla Hardnett,Christina Hutson,Crystal M Gigante,Laura Quilter,Ian Kracalik,Stephanie Black,Andrea M McCollum,Agam K Rao,Irina Tabidze
-
E-cigarette Unit Sales by Product and Flavor Type, and Top-Selling Brands, United States, 2020-2022. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-23 Fatma Romeh M Ali,Andrew B Seidenberg,Elisha Crane,Elizabeth Seaman,Michael A Tynan,Kristy Marynak
E-cigarette products, related policies, and use patterns change rapidly. In the United States, the prevalence of e-cigarette use is markedly higher among youths and young adults than it is among adults overall. In 2021, 4.5% of all adults aged ≥18 years (an estimated 11.1 million) and 11.0% of young adults aged 18-24 years (an estimated 3.1 million) currently (≥1 day during the previous 30 days) used
-
Notes from the Field: E-Cigarette-Associated Cases Reported to Poison Centers - United States, April 1, 2022-March 31, 2023. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-23 Nicole A Tashakkori,Brian L Rostron,Carol H Christensen,Karen A Cullen
-
Progress Toward Rubella Elimination - World Health Organization South-East Asia Region, 2013-2021. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-23 Sudhir Khanal,Sunil Bahl,Lucky Sangal,Deepak Dhongde,Patrick Michael O'Connor,Natasha S Crowcroft,Michelle Morales
During 2013, the 11 countries of the World Health Organization (WHO) South-East Asia Region* (SEAR) adopted the goals of measles elimination and rubella and congenital rubella syndrome (CRS) control† by 2020. During 2019, SEAR countries declared a broader goal for eliminating both measles and rubella§ by 2023 (1). Before 2013, only five SEAR countries had introduced rubella-containing vaccine (RCV)
-
-
Effectiveness of Up-to-Date COVID-19 Vaccination in Preventing SARS-CoV-2 Infection Among Nursing Home Residents - United States, November 20, 2022-January 8, 2023. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-23 Emily Wong,Kira Barbre,Ryan E Wiegand,Hannah E Reses,Heather Dubendris,Megan Wallace,Philip Dollard,Jonathan Edwards,Minn Soe,Lu Meng,Andrea Benin,Jeneita M Bell
Nursing home residents have been disproportionately affected by the COVID-19 pandemic; their age, comorbidities, and exposure to a congregate setting has placed them at high risk for both infection and severe COVID-19-associated outcomes, including death (1). Receipt of a primary COVID-19 mRNA vaccination series (2) and monovalent booster doses (3) have been demonstrated to be effective in reducing
-
-
Notes from the Field: Tetanus in an Unvaccinated Man from Mexico - Oregon, 2022. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-16 Corey Pierce,Angela Holly Villamagna,Paul Cieslak,Juventila Liko
-
Notes from the Field: Comparison of COVID-19 Mortality Rates Among Adults Aged ≥65 Years Who Were Unvaccinated and Those Who Received a Bivalent Booster Dose Within the Preceding 6 Months - 20 U.S. Jurisdictions, September 18, 2022-April 1, 2023. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-16 Amelia G Johnson,Lauren Linde,Amanda B Payne,Akilah R Ali,Vanessa Aden,Brandy Armstrong,Brett Armstrong,Steven Auche,Nagla S Bayoumi,Sarah Bennett,Rachelle Boulton,Carolyn Chang,Abigail Collingwood,Kevin Cueto,Sherri L Davidson,Yi Du,Aaron Fleischauer,Victoria Force,Darren Frank,Ross Hamilton,Kaitlin Harame,Pauline Harrington,Liam Hicks,Jeffrey D Hodis,Mikhail Hoskins,Amanda Jones,Fnu Kanishka,Ramandeep
-
Interim Recommendations for Use of Bivalent mRNA COVID-19 Vaccines for Persons Aged ≥6 Months - United States, April 2023. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-16 Danielle L Moulia,Megan Wallace,Lauren E Roper,Monica Godfrey,Hannah G Rosenblum,Ruth Link-Gelles,Amadea Britton,Matthew F Daley,Sarah Meyer,Katherine E Fleming-Dutra,Sara E Oliver,Evelyn Twentyman
Throughout the national public health emergency declared in response to the COVID-19 pandemic, CDC, guided by the Advisory Committee on Immunization Practices (ACIP), has offered evidence-based recommendations for the use of COVID-19 vaccines in U.S. populations after each regulatory action by the Food and Drug Administration (FDA). During August 2022-April 2023, FDA amended its Emergency Use Authorizations
-
Notes from the Field: Increase in Meningococcal Disease Among Persons with HIV - United States, 2022. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-16 Amy B Rubis,Rebecca L Howie,Daya Marasini,Shalabh Sharma,Henju Marjuki,Lucy A McNamara
-
Genomic Surveillance for SARS-CoV-2 Variants: Circulation of Omicron Lineages - United States, January 2022-May 2023. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-16 Kevin C Ma,Philip Shirk,Anastasia S Lambrou,Norman Hassell,Xiao-Yu Zheng,Amanda B Payne,Akilah R Ali,Dhwani Batra,Jason Caravas,Reina Chau,Peter W Cook,Dakota Howard,Nicholas A Kovacs,Kristine A Lacek,Justin S Lee,Duncan R MacCannell,Lakshmi Malapati,Sandra Mathew,Neha Mittal,Roopa R Nagilla,Rishika Parikh,Prabasaj Paul,Benjamin L Rambo-Martin,Samuel S Shepard,Mili Sheth,David E Wentworth,Amber Winn
CDC has used national genomic surveillance since December 2020 to monitor SARS-CoV-2 variants that have emerged throughout the COVID-19 pandemic, including the Omicron variant. This report summarizes U.S. trends in variant proportions from national genomic surveillance during January 2022-May 2023. During this period, the Omicron variant remained predominant, with various descendant lineages reaching
-
National, State-Level, and County-Level Prevalence Estimates of Adults Aged ≥18 Years Self-Reporting a Lifetime Diagnosis of Depression - United States, 2020. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-16 Benjamin Lee,Yan Wang,Susan A Carlson,Kurt J Greenlund,Hua Lu,Yong Liu,Janet B Croft,Paul I Eke,Machell Town,Craig W Thomas
Depression is a major contributor to mortality, morbidity, disability, and economic costs in the United States (1). Examining the geographic distribution of depression at the state and county levels can help guide state- and local-level efforts to prevent, treat, and manage depression. CDC analyzed 2020 Behavioral Risk Factor Surveillance System (BRFSS) data to estimate the national, state-level, and
-
Notes from the Field: Rift Valley Fever Outbreak - Mbarara District, Western Uganda, January-March 2023. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-09 Zainah Kabami,Alex R Ario,Richard Migisha,Helen Nelly Naiga,Annet Martha Nankya,Peter Ssebutinde,Christopher Nahabwe,Santos Omia,Francis Mugabi,David Muwanguzi,Allan Muruta,Joshua Kayiwa,Samuel Gidudu,Daniel Kadobera,Luke Nyakarahuka,Jimmy Baluku,Stephen Balinandi,Caitlin M Cossaboom,Julie R Harris
-
-
Progress Toward Equitable Mpox Vaccination Coverage: A Shortfall Analysis - United States, May 2022-April 2023. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-09 Krishna Kiran Kota,Harrell Chesson,Jaeyoung Hong,Carla Zelaya,Ian H Spicknall,Aspen P Riser,Elizabeth Hurley,Dustin W Currie,R Ryan Lash,Neal Carnes,Jeniffer Concepción-Acevedo,Sascha Ellington,Ermias D Belay,Jonathan Mermin
More than 30,000 monkeypox (mpox) cases were reported in the United States during the 2022 multinational outbreak; cases disproportionately affected gay, bisexual, and other men who have sex with men (MSM). Substantial racial and ethnic disparities in incidence were also reported (1). The national mpox vaccination strategy* emphasizes that efforts to administer the JYNNEOS mpox vaccine should be focused
-
Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months-5 Years - United States, June 17, 2022-May 7, 2023. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-09 Anne M Hause,Paige Marquez,Bicheng Zhang,Pedro L Moro,Tanya R Myers,Colin Bradley,Samaneh Bazel,Sarada S Panchanathan,Tom T Shimabukuro,David K Shay
As of May 7, 2023, CDC's Advisory Committee on Immunization Practices (ACIP) recommends that all children aged 6 months-5 years receive at least 1 age-appropriate bivalent mRNA COVID-19 vaccine dose. Depending on their COVID-19 vaccination history and history of immunocompromise, these children might also need additional doses* (1-3). Initial vaccine safety findings after primary series vaccination
-
Notes from the Field: Exposures to Mpox Among Cases in Children Aged ≤12 Years - United States, September 25-December 31, 2022. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-09 Kaylea Nemechek,Ruth Stefanos,Erin L Miller,Aspen Riser,Bethel Kebede,Romeo R Galang,Kaitlin Hufstetler,Denisse Descamps,Adelaide Balenger,Ian Hennessee,Varsha Neelam,Helena J Hutchins,Sarah M Labuda,K Meryl Davis,David W McCormick,Grace E Marx,Anne Kimball,Irene Ruberto,Thomas Williamson,Paul Rzucidlo,Christina Willut,Rachel E Harold,Anil T Mangla,Andrew English,Danucha Brikshavana,Justin Blanding
-
Surveillance To Track Progress Toward Poliomyelitis Eradication - Worldwide, 2021-2022. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-09 Tasha Stehling-Ariza,Amanda L Wilkinson,Ousmane M Diop,Jaume Jorba,Humayun Asghar,Tigran Avagnan,Varja Grabovac,Ticha Johnson,Sudhir Joshi,Anfumbom K W Kfutwah,Lucky Sangal,Salmaan Sharif,Ashraf Wahdan,Graham F Tallis,Stephanie D Kovacs
Since the Global Polio Eradication Initiative (GPEI) was established in 1988, the number of wild poliovirus (WPV) cases has declined by >99.9%, and WPV serotypes 2 and 3 have been declared eradicated (1). By the end of 2022, WPV type 1 (WPV1) transmission remained endemic only in Afghanistan and Pakistan (2,3). However, during 2021-2022, Malawi and Mozambique reported nine WPV1 cases that were genetically
-
Notes from the Field: Chikungunya Outbreak - Paraguay, 2022-2023. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-09 Martha Torales,Amy Beeson,Lorena Grau,Miguel Galeano,Andrea Ojeda,Bettiana Martinez,Nancy León,Agueda Cabello,Fátima Rojas,Viviana de Egea,Rosa Galeano,Sandra Ocampos,Cynthia Vazquez,Romeo Montoya,Susan Hills,Guillermo Sequera
-
-
Notes from the Field: Update on Pediatric Intracranial Infections - 19 States and the District of Columbia, January 2016-March 2023. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-02 Emma K Accorsi,Matt Hall,Adam L Hersh,Samir S Shah,Stephanie J Schrag,Adam L Cohen
-
Notes from the Field: Pediatric Intracranial Infections - Clark County, Nevada, January-December 2022. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-02 Jessica A Penney,Ying Zhang,Taryn Bragg,Rachel Bryant,Cassius Lockett
-
Estimates of SARS-CoV-2 Seroprevalence and Incidence of Primary SARS-CoV-2 Infections Among Blood Donors, by COVID-19 Vaccination Status - United States, April 2021-September 2022. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-02 Jefferson M Jones,Irene Molina Manrique,Mars S Stone,Eduard Grebe,Paula Saa,Clara D Germanio,Bryan R Spencer,Edward Notari,Marjorie Bravo,Marion C Lanteri,Valerie Green,Melissa Briggs-Hagen,Melissa M Coughlin,Susan L Stramer,Jean Opsomer,Michael P Busch
Changes in testing behaviors and reporting requirements have hampered the ability to estimate the U.S. SARS-CoV-2 incidence (1). Hybrid immunity (immunity derived from both previous infection and vaccination) has been reported to provide better protection than that from infection or vaccination alone (2). To estimate the incidence of infection and the prevalence of infection- or vaccination-induced
-
Evaluation of the Cherokee Nation Hepatitis C Virus Elimination Program - Cherokee Nation, Oklahoma, 2015-2020. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-02 Whitney Essex,Molly Feder,Jorge Mera
Approximately 2.4 million persons in the United States have hepatitis C virus (HCV) infection, and 66,700 acute HCV infection cases were estimated for 2020 (1,2). American Indian or Alaska Native (AI/AN) persons are disproportionately affected by HCV infection and experienced the highest rates of acute HCV infection (2.1 cases per 100,000 persons) and HCV-associated mortality (10.17 per 100,000 persons)
-
Community Water Fluoridation Levels To Promote Effectiveness and Safety in Oral Health - United States, 2016-2021. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-06-02 Theresa J Boehmer,Srdjan Lesaja,Lorena Espinoza,Chandresh N Ladva
Drinking water fluoridated at the level recommended by the U.S. Public Health Service (USPHS) reduces dental caries (cavities) by approximately 25% in children and adults (1). USPHS recommends fluoride levels to achieve oral health benefits and minimize risks associated with excess fluoride exposure. To provide the benefits of community water fluoridation, water systems should target a level of 0.7
-
-
Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-05-26 Ruth Link-Gelles,Zachary A Weber,Sarah E Reese,Amanda B Payne,Manjusha Gaglani,Katherine Adams,Anupam B Kharbanda,Karthik Natarajan,Malini B DeSilva,Kristin Dascomb,Stephanie A Irving,Nicola P Klein,Shaun J Grannis,Toan C Ong,Peter J Embi,Margaret M Dunne,Monica Dickerson,Charlene McEvoy,Julie Arndorfer,Allison L Naleway,Kristin Goddard,Brian E Dixon,Eric P Griggs,John Hansen,Nimish Valvi,Morgan Najdowski
On September 1, 2022, CDC's Advisory Committee on Immunization Practices (ACIP) recommended a single bivalent mRNA COVID-19 booster dose for persons aged ≥12 years who had completed at least a monovalent primary series. Early vaccine effectiveness (VE) estimates among adults aged ≥18 years showed receipt of a bivalent booster dose provided additional protection against COVID-19-associated emergency
-
Urban and Rural Mpox Incidence Among Persons Aged 15-64 Years - United States, May 10-December 31, 2022. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-05-26 Carla E Zelaya,Brandi P Smith,Aspen P Riser,Jaeyoung Hong,Samantha Distler,Siobhán O'Connor,Ermias Belay,Mohammad Shoeb,Michelle A Waltenburg,Maria E Negron,Sascha Ellington
During May 10-December 31, 2022, a total of 29,980 confirmed and probable† U.S. monkeypox (mpox) cases were reported to CDC, predominantly in cisgender adult men reporting recent same-gender sexual partners (1). Urban-rural differences in health (2) and diagnosis of HIV (3,4) and other sexually transmitted infections (5) are well documented nationally. This report describes urban-rural differences
-
Potential for Recurrent Mpox Outbreaks Among Gay, Bisexual, and Other Men Who Have Sex with Men - United States, 2023. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-05-26 Emily D Pollock,Patrick A Clay,Adrienne Keen,Dustin W Currie,Rosalind J Carter,Laura A S Quilter,Adi V Gundlapalli,Jonathan Mermin,Ian H Spicknall
More than 30,000 monkeypox (mpox) cases have been diagnosed in the United States since May 2022, primarily among gay, bisexual, and other men who have sex with men (MSM) (1,2). In recent months, diagnoses have declined to one case per day on average. However, mpox vaccination coverage varies regionally, suggesting variable potential risk for mpox outbreak recurrence (3). CDC simulated dynamic network
-
Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection - New York, 2022. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-05-19 Eli S Rosenberg,Vajeera Dorabawila,Rachel Hart-Malloy,Bridget J Anderson,Wilson Miranda,Travis O'Donnell,Charles J Gonzalez,Meaghan Abrego,Charlotte DelBarba,Cori J Tice,Claire McGarry,Ethan C Mitchell,Michele Boulais,Bryon Backenson,Michael Kharfen,James McDonald,Ursula E Bauer
In 2022, an international Monkeypox virus outbreak, characterized by transmission primarily through sexual contact among gay, bisexual, and other men who have sex with men (MSM), resulted in 375 monkeypox (mpox) cases in the state of New York outside of New York City (NYC).*,† The JYNNEOS vaccine (Modified Vaccinia Ankara vaccine, Bavarian Nordic), licensed by the U.S. Food and Drug Administration
-
The CDC Domestic Mpox Response - United States, 2022-2023. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-05-19 Jennifer H McQuiston,Christopher R Braden,Michael D Bowen,Andrea M McCollum,Robert McDonald,Neal Carnes,Rosalind J Carter,Athalia Christie,Jeffrey B Doty,Sascha Ellington,S Nicole Fehrenbach,Adi V Gundlapalli,Christina L Hutson,Rachel E Kachur,Aaron Maitland,Christine M Pearson,Joseph Prejean,Laura A S Quilter,Agam K Rao,Yon Yu,Jonathan Mermin
Monkeypox (mpox) is a serious viral zoonosis endemic in west and central Africa. An unprecedented global outbreak was first detected in May 2022. CDC activated its emergency outbreak response on May 23, 2022, and the outbreak was declared a Public Health Emergency of International Concern on July 23, 2022, by the World Health Organization (WHO),* and a U.S. Public Health Emergency on August 4, 2022
-
QuickStats: Percentage* of Children and Adolescents Aged 5-17 Years Who Received Free or Reduced-Cost Meals at School During the Previous 12 Months,† by Race and Hispanic Ethnicity§ and Family Income¶ - National Health Interview Survey, United States, 2021. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-05-19
-
Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study - United States, August 19, 2022-March 31, 2023. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-05-19 Alexandra F Dalton,Alpha Oumar Diallo,Anna N Chard,Danielle L Moulia,Nicholas P Deputy,Amy Fothergill,Ian Kracalik,Christopher W Wegner,Tiffanie M Markus,Preeti Pathela,William L Still,Sam Hawkins,Anil T Mangla,Nivedita Ravi,Erin Licherdell,Amber Britton,Ruth Lynfield,Melissa Sutton,AmberJean P Hansen,Gabriela S Betancourt,Jemma V Rowlands,Shua J Chai,Rebecca Fisher,Phoebe Danza,Monica Farley,Jennifer
As of March 31, 2023, more than 30,000 monkeypox (mpox) cases had been reported in the United States in an outbreak that has disproportionately affected gay, bisexual, and other men who have sex with men (MSM) and transgender persons (1). JYNNEOS vaccine (Modified Vaccinia Ankara vaccine, Bavarian Nordic) was approved by the Food and Drug Administration (FDA) in 2019 for the prevention of smallpox
-
Notes from the Field: Legionnaires Disease in a U.S. Traveler After Staying in a Private Vacation Rental House in the U.S. Virgin Islands - United States, February 2022. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-05-19 Valerie V Mac,Katie Labgold,Heidi L Moline,Jessica C Smith,Jamaal Carroll,Nakia Clemmons,Chris Edens,Brett Ellis,Cosme Harrison,Kelley C Henderson,Maliha K Ishaq,Natalia A Kozak-Muiznieks,Jasen Kunz,Marlon Lawrence,Claressa E Lucas,Heather L Walker,Melisa J Willby,Esther M Ellis
-
Prevalence of Disability by Occupation Group - United States, 2016-2020. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-05-19 Taylor M Shockey,Kelsie Fox,Guixiang Zhao,NaTasha Hollis
In 2020, approximately 21.5 million employed U.S. adults aged 18-64 years had some form of disability. Although 75.8% of noninstitutionalized persons without disability aged 18-64 were employed, only 38.4% of their counterparts with disability were employed (1). Persons with disability have job preferences similar to persons without disability but might encounter barriers (e.g., lower average training
-
Correlations and Timeliness of COVID-19 Surveillance Data Sources and Indicators - United States, October 1, 2020-March 22, 2023. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-05-12 Heather M Scobie,Mark Panaggio,Alison M Binder,Molly E Gallagher,William M Duck,Philip Graff,Benjamin J Silk
When the U.S. COVID-19 public health emergency declaration expires on May 11, 2023, national reporting of certain categories of COVID-19 public health surveillance data will be transitioned to other data sources or will be discontinued; COVID-19 hospitalization data will be the only data source available at the county level (1). In anticipation of the transition, national COVID-19 surveillance data
-
Notes from the Field: First Reported U.S. Cases of Tinea Caused by Trichophyton indotineae - New York City, December 2021-March 2023. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-05-12 Avrom S Caplan,Sudha Chaturvedi,YanChun Zhu,Gabrielle C Todd,Lu Yin,Adriana Lopez,Lisa Travis,Dallas J Smith,Tom Chiller,Shawn R Lockhart,Karen A Alroy,William G Greendyke,Jeremy A W Gold
-
-
COVID-19 Surveillance After Expiration of the Public Health Emergency Declaration - United States, May 11, 2023. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-05-12 Benjamin J Silk,Heather M Scobie,William M Duck,Tess Palmer,Farida B Ahmad,Alison M Binder,Jodi A Cisewski,Seth Kroop,Karl Soetebier,Meeyoung Park,Aaron Kite-Powell,Andrea Cool,Erin Connelly,Stephanie Dietz,Amy E Kirby,Kathleen Hartnett,Jocelyn Johnston,Diba Khan,Shannon Stokley,Clinton R Paden,Michael Sheppard,Paul Sutton,Hilda Razzaghi,Robert N Anderson,Natalie Thornburg,Sarah Meyer,Caryn Womack
On January 31, 2020, the U.S. Department of Health and Human Services (HHS) declared, under Section 319 of the Public Health Service Act, a U.S. public health emergency because of the emergence of a novel virus, SARS-CoV-2.* After 13 renewals, the public health emergency will expire on May 11, 2023. Authorizations to collect certain public health data will expire on that date as well. Monitoring the
-
Progress Toward Poliomyelitis Eradication - Worldwide, January 2021-March 2023. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-05-12 Scarlett E Lee,Sharon A Greene,Cara C Burns,Graham Tallis,Steven G F Wassilak,Omotayo Bolu
Since the World Health Assembly established the Global Polio Eradication Initiative (GPEI) in 1988, two of the three wild poliovirus (WPV) serotypes (types 2 and 3) have been eradicated, and global WPV cases have decreased by more than 99.9%. Afghanistan and Pakistan remain the only countries where indigenous WPV type 1 (WPV1) transmission has not been interrupted. This report summarizes progress toward
-
Multistate Outbreak of Salmonella Thompson Infections Linked to Seafood Exposure - United States, 2021. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-05-12 Ann Q Shen,Alyssa Dalen,Laura Bankers,Shannon R Matzinger,Colin Schwensohn,Kane Patel,Kelley B Hise,Evelyn Pereira,Jennifer Cripe,Rachel H Jervis
In July 2021, the Colorado Department of Public Health and Environment (CDPHE) laboratory identified a cluster of five Salmonella enterica serotype Thompson isolates related to one another within one allele difference, using whole genome multilocus sequence typing (wgMLST). These five isolates, submitted to the public health laboratory as is routine process for confirmatory testing of Salmonella, were
-
Emergency Department Visits Involving Mental Health Conditions, Suicide-Related Behaviors, and Drug Overdoses Among Adolescents - United States, January 2019-February 2023. Morb. Mortal. Wkly. Rep. (IF 33.9) Pub Date : 2023-05-12 Kayla N Anderson,Dylan Johns,Kristin M Holland,Yushiuan Chen,Alana M Vivolo-Kantor,Eva Trinh,Rebecca H Bitsko,Rebecca T Leeb,Lakshmi Radhakrishnan,Sarah Bacon,Christopher M Jones
The U.S. adolescent mental and behavioral health crisis is ongoing,* with high pre-COVID-19 pandemic baseline rates† (1) and further increases in poor mental health (2), suicide-related behaviors (3), and drug overdose deaths (4) reported during 2020-2021. CDC examined changes in U.S. emergency department (ED) visits for mental health conditions (MHCs) overall and for nine specific MHCs,§ suicide-related